ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer
חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3
מצבים רפואיים
Small Cell Lung Cancer
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Beijing Cancer Hospital, Beijing, Beijing Municipality, China
Contact: Principal Investigator (Jian Fang)Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
Contact: Principal Investigator (Baogang Liu)Henan Cancer Hospital, Zhengzhou, Henan, China
Contact: Principal Investigator (Qiming Liu)Jilin Cancer Hospital, Changchun, Jilin, China
Contact: Principal Investigator (Ying Cheng)Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
Contact: Principal Investigator (Wei Zheng)Shandong Cancer Hospital, Jinan, Shandong, China
Contact: Principal Investigator (Haiyong Wang)Shanghai Pulmonary Hospital, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Peng Zhang)Contact: Principal Investigator (Peng Zhang)The First Affiliate Hospital of GUANGZHOU Medical University, Guangzhou, China
Contact: Principal Investigator (Ming Liu)Tongji Hospital, Wuhan, China
Contact: Principal Investigator (Qian Chu)